KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for BeOne Medicines (ONC) over the last 10 years, with Q3 2025 value amounting to 0.04%.

  • BeOne Medicines' Return on Capital Employed rose 2700.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.16% for FY2024, which is 1600.0% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Return on Capital Employed is 0.04%, which was up 2700.0% from 0.03% recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Return on Capital Employed peaked at 0.04% during Q3 2025, and registered a low of 0.38% during Q1 2023.
  • Its 5-year average for Return on Capital Employed is 0.22%, with a median of 0.24% in 2024.
  • As far as peak fluctuations go, BeOne Medicines' Return on Capital Employed plummeted by -2200bps in 2022, and later soared by 2700bps in 2025.
  • Quarter analysis of 5 years shows BeOne Medicines' Return on Capital Employed stood at 0.13% in 2021, then tumbled by -171bps to 0.35% in 2022, then rose by 9bps to 0.31% in 2023, then surged by 50bps to 0.16% in 2024, then surged by 126bps to 0.04% in 2025.
  • Its Return on Capital Employed was 0.04% in Q3 2025, compared to 0.03% in Q2 2025 and 0.08% in Q1 2025.